FPGK
ABBV icon

Financial Partners Group (Kansas)’s AbbVie ABBV Stock Holding History

Financial Partners Group (Kansas)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Buy
2,252
+212
+10% +$45.6K 0.06% 143
2026
Q1 		$444K Sell
2,040
-77
-4% -$17.1K 0.05% 152
2025
Q4 		$472K Buy
2,117
+74
+4% +$16.9K 0.05% 146
2025
Q3 		$473K Buy
2,043
+559
+38% +$114K 0.06% 135
2025
Q2 		$275K Buy
1,484
+10
+0.7% +$1.86K 0.04% 168
2025
Q1 		$309K Sell
1,474
-678
-32% -$132K 0.05% 143
2024
Q4 		$382K Sell
2,152
-37
-2% -$6.8K 0.06% 122
2024
Q3 		$432K Buy
2,189
+8
+0.4% +$1.49K 0.06% 117
2024
Q2 		$374K Sell
2,181
-499
-19% -$82.7K 0.06% 122
2024
Q1 		$488K Buy
2,680
+1,019
+61% +$176K 0.08% 108
2023
Q4 		$257K Sell
1,661
-52
-3% -$7.58K 0.05% 138
2023
Q3 		$236K Buy
1,713
+278
+19% +$40.8K 0.05% 137
2023
Q2 		$212K Sell
1,435
-1,116
-44% -$164K 0.04% 146
2023
Q1 		$407K Buy
2,551
+210
+9% +$32.1K 0.09% 98
2022
Q4 		$360K Buy
+2,341
New +$359K 0.08% 110
2022
Q3 		– Sell
-1,356
Closed -$208K – 144
2022
Q2 		$208K Buy
1,356
+6
+0.4% +$917 0.05% 138
2022
Q1 		$219K Buy
+1,350
New +$196K 0.05% 151

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Financial Partners Group (Kansas)'s ABBV Position: Q2 2026 in Review

Financial Partners Group (Kansas) increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $45.6K and bringing the position to 2,252 shares worth $567K. The position accounts for 0.06% of the portfolio, ranked #143.

Financial Partners Group (Kansas) first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Financial Partners Group (Kansas) held 2,252 shares of AbbVie worth $567K as of Q2 2026.
  • Financial Partners Group (Kansas) bought 212 AbbVie shares in Q2 2026, an estimated $45.6K.
  • AbbVie made up 0.06% of Financial Partners Group (Kansas)'s portfolio in Q2 2026, its #143 holding.
  • Financial Partners Group (Kansas) first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Financial Partners Group (Kansas)'s 13F filing for Q2 2026, filed 23 Jul 2026.